Additional Approvals for Bisono® Tape, a Transdermal Patch containing a β1 Blocker, for Atrial Fibrillation, for a 2 mg strength and for improved formulations of 4 mg and 8 mg strengths in Japan
Tokyo: January 8, 2019 - Toa Eiyo Ltd. (President: Atsuo Takahashi, Ph.D., “Toa Eiyo”) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D.) announced today that Toa Eiyo received approvals for Bisono ® Tape 2 mg, Bisono ® Tape 4 mg and Bisono ® Tape 8 mg (collectively, “Bisono ® Tape”, non-proprietary name: bisoprolol), transdermal patches containing a β 1 blocker, in...
Read More